Stock Scorecard
Stock Summary for Medifast Inc (MED) - $10.91 as of 11/26/2025 3:20:09 PM EST
Total Score
15 out of 30
Safety Score
37 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for MED
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MED
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MED
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for MED
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for MED (37 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 7 |
| Book Value to Price (Max of 10) | 8 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 1 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for MED
Financial Details for MED
Company Overview |
|
|---|---|
| Ticker | MED |
| Company Name | Medifast Inc |
| Country | USA |
| Description | Medifast, Inc. is a prominent player in the health and nutrition sector, renowned for its innovative weight loss and management solutions, coupled with a holistic lifestyle approach. Headquartered in Baltimore, Maryland, the company employs a direct-to-consumer model to foster strong customer loyalty and expand its market presence, particularly in the U.S. and Asia-Pacific regions. With a solid commitment to science-backed nutritional products, Medifast is well-positioned to capture the growing global demand for health and wellness solutions, thereby offering significant growth potential in an increasingly health-conscious marketplace. |
| Sector Name | CONSUMER CYCLICAL |
| Industry Name | PERSONAL SERVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 10.91 |
| Price 4 Years Ago | 189.26 |
| Last Day Price Updated | 11/26/2025 3:20:09 PM EST |
| Last Day Volume | 254,128 |
| Average Daily Volume | 186,801 |
| 52-Week High | 21.98 |
| 52-Week Low | 10.36 |
| Last Price to 52 Week Low | 5.31% |
Valuation Measures |
|
| Trailing PE | 529.50 |
| Industry PE | 75.58 |
| Sector PE | 32.04 |
| 5-Year Average PE | -38.02 |
| Free Cash Flow Ratio | 1.21 |
| Industry Free Cash Flow Ratio | 97.01 |
| Sector Free Cash Flow Ratio | 29.34 |
| Current Ratio Most Recent Quarter | 4.45 |
| Total Cash Per Share | 9.05 |
| Book Value Per Share Most Recent Quarter | 20.89 |
| Price to Book Ratio | 0.55 |
| Industry Price to Book Ratio | 14.42 |
| Sector Price to Book Ratio | 8.64 |
| Price to Sales Ratio Twelve Trailing Months | 0.27 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.98 |
| Sector Price to Sales Ratio Twelve Trailing Months | 1.67 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 10,991,300 |
| Market Capitalization | 119,915,083 |
| Institutional Ownership | 85.89% |
Dividends |
|
| Ex-Dividend Date | 9/18/2023 |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 1.6500 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 7.26 |
| Forward Annual Dividend Yield | 42.88% |
| 5-Year Dividend Payments Count | 16 |
| 3-Year Average Dividend Yield | 6.53% |
| 5-Year Average Dividend Yield | 4.52% |
| 1-Year Dividend Growth Rate Percentage | 33.33% |
| 3-Year Dividend Growth Rate Percentage | 0.30% |
| 5-Year Dividend Growth Rate Percentage | 9.93% |
| All-Time Dividend Growth Rate Percentage | 45.24% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -87.20% |
| Annual Earnings Growth | -97.90% |
| Reported EPS 12 Trailing Months | 0.02 |
| Reported EPS Past Year | -0.06 |
| Reported EPS Prior Year | 2.03 |
| Net Income Twelve Trailing Months | 248,000 |
| Net Income Past Year | 2,091,000 |
| Net Income Prior Year | 99,415,000 |
| Quarterly Revenue Growth YOY | -36.20% |
| 5-Year Revenue Growth | -3.33% |
| Operating Margin Twelve Trailing Months | -4.56% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 99,526,000 |
| Total Cash Past Year | 90,928,000 |
| Total Cash Prior Year | 94,440,000 |
| Net Cash Position Most Recent Quarter | 72,526,000 |
| Net Cash Position Past Year | 90,928,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 27,000,000 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 0.89 |
| Total Stockholder Equity Past Year | 210,109,000 |
| Total Stockholder Equity Prior Year | 201,481,000 |
| Total Stockholder Equity Most Recent Quarter | 214,706,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 646,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.06 |
| Free Cash Flow Past Year | 17,022,000 |
| Free Cash Flow Prior Year | 141,174,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.59 |
| MACD Signal | -0.52 |
| 20-Day Bollinger Lower Band | 10.70 |
| 20-Day Bollinger Middle Band | 13.06 |
| 20-Day Bollinger Upper Band | 15.41 |
| Beta | 0.50 |
| RSI | 30.13 |
| 50-Day SMA | 14.03 |
| 150-Day SMA | 43.32 |
| 200-Day SMA | 67.43 |
System |
|
| Modified | 11/25/2025 3:54:54 AM EST |